4//SEC Filing
Reynoso Jamie L. 4
Accession 0001801170-26-000024
CIK 0001801170other
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 5:38 PM ET
Size
7.5 KB
Accession
0001801170-26-000024
Insider Transaction Report
Form 4
Reynoso Jamie L.
CEO, Medicare Advantage
Transactions
- Tax Payment
Class A Common Stock
[F1]2026-01-15$2.81/sh−14,732$41,397→ 2,742,297 total - Sale
Class A Common Stock
[F2]2026-01-20$2.58/sh−4,597$11,860→ 2,737,700 total
Footnotes (2)
- [F1]Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on January 15, 2026, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on October 15, 2024, and timely reported on a Form 4 filed on October 17, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date.
- [F2]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.47 to $2.63, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Signature
/s/Peter J. Rivas as attorney-in-fact for Jamie L. Reynoso|2026-01-20
Documents
Issuer
CLOVER HEALTH INVESTMENTS, CORP. /DE
CIK 0001801170
Entity typeother
Related Parties
1- filerCIK 0001839066
Filing Metadata
- Form type
- 4
- Filed
- Jan 19, 7:00 PM ET
- Accepted
- Jan 20, 5:38 PM ET
- Size
- 7.5 KB